The largest database of trusted experimental protocols

Spin filter

Manufactured by Merck Group
Sourced in United Kingdom, Germany

The Spin filter is a laboratory equipment used for separating and concentrating biological samples, such as proteins, nucleic acids, or cells, from a liquid solution. It operates on the principle of centrifugation, where the sample is loaded into a specialized filter device and spun at high speed, causing the desired components to be retained while the unwanted materials pass through the filter membrane.

Automatically generated - may contain errors

15 protocols using spin filter

1

Purification of EGFR Nanodiscs

Check if the same lab product or an alternative is used in the 5 most similar protocols
500 μL of Ni-NTA resin slurry (Qiagen) was added to a 2 mL plastic column (Bio-Rad Laboratories). The resin was washed with double distilled water and equilibrated with 3 mL of native lysis buffer (50 mM NaH2PO4, 300 mM NaCl, pH 8.0). The cell-free reaction post labeling was added to 500 μL of lysis buffer on the equilibrated column and incubated at 4 °C for 2 h. The flowthrough was collected and the column was washed with lysis buffer (10 × 1 mL) followed by lysis buffer containing 10 mM imidazole (2 × 1 mL), lysis buffer containing 25 mM imidazole (2 × 1 mL), and lysis buffer containing 50 mM imidazole (2 × 1 mL) to remove all the non-specific interactions of the reaction mixture and free dye from the column. The EGFR nanodiscs were eluted with lysis buffer containing 400 mM (2 × 500 μL) imidazole. The samples were finally concentrated using 50 kDa, 500 μL spin filters (Sigma-Aldrich) by centrifugation.
+ Open protocol
+ Expand
2

Plasma Preparation for Canine IgE Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected from dogs before an IDT or serum immunoglobulin (Ig)E blood test. Blood samples were separated by gradient centrifugation immediately, or otherwise either stored in 4°C or shipped on ice, and then separated within 4 h of collection. Plasma samples were stored at –80°C before analysis. Before assay, plasma samples were thawed on ice and diluted with either a water‐soluble protease inhibitor cocktail (Sigma‐Aldrich; St Louis, MO, USA) or proprietary diluents according to the manufacturer’s instructions. Plasma samples for the single‐plex TGFβ immunoassay were acid‐treated, then neutralised, clarified by centrifugation (20,000g; 10 min), and filtered using spin filters (0.22 µ; Sigma‐Aldrich). The filtrates were stored short‐term at –20°C before assay.
+ Open protocol
+ Expand
3

Vasa cDNA Amplification and Labeling

Check if the same lab product or an alternative is used in the 5 most similar protocols
vasa cDNA was provided by H. Knaut (NYU Medical Center and School of Medicine, USA) in a pBS+ cloning vector. The vector conferred ampicillin resistance and contained M13 primer binding sites flanking the vasa cDNA. vasa cDNA containing plasmid was transformed into NEB 10-beta competent E.coli, and purified using a Miniprep kit (Qiagen, UK). The DNA template for the vasa RNA probe was then produced using a standard PCR protocol with M13 primers (Forward: 5’gtaaaacgcggccagt3’, Reverse: 5’ggaaacagctatgaccatg 3’), and purified using a 50 kDal centrifugal filter unit (Amicon, UK). Anti-sense RNA probes were transcribed from the DNA template using digoxigenin (DIG)-11-UTP Labelling Mix (Roche, UK), cleaned using spin filters (Sigma-Aldrich) and eluted into RNA-later (Sigma-Aldrich, UK) before storing at -20°C.
+ Open protocol
+ Expand
4

Protein Extraction and Preparation for MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in 150 µl lysis buffer (10% SDS, 150 mM NaCl, 100 mM Hepes NaOH pH 7.6) and DNA was sheared by sonication for 5 s. Cell lysates were cleared by centrifugation at 16,000 g for 3 min. 20 µg of total protein were diluted in 4% (w/v) SDS, 100 mM HEPES/NaOH pH 7.6, 150 mM NaCl, 0.1 M DTT and heated at 95°C for 5 min. The lysates were then mixed with 200 µl 8 M urea, 50 mM Tris/HCl, pH 8.5 and loaded onto spin filters with 30 kDa cut-off (Microcon, Merck, Germany). The filter-aided sample preparation protocol (FASP) was essentially followed (Wiśniewski et al., 2009 (link)). Proteins were digested overnight with trypsin (sequencing grade, Promega). According to Kulak et al. (2014 (link)), acidified peptides (0.1% trifluoroacetic acid final concentration) were desalted with C18 StageTips and fractionated with strong cation exchange (SCX) StageTips. The C18 trans-elution fraction was combined with the first of 6 SCX fractions. Peptides were dried and resolved in 1% acetonitrile, 0.1% formic acid.
+ Open protocol
+ Expand
5

Production and Purification of Fab Fragments

Check if the same lab product or an alternative is used in the 5 most similar protocols
HyHEL5 and HyHEL10 heavy- and kappa light-chain Fab sequences were synthesized and cloned into the pCEP4 expression vector (Thermo Fisher Scientific) via KpnI and BamHI restriction sites. Heavy chains were C-terminally His-tagged for purification purposes. Fab fragments were transiently expressed using the Expi293 Expression System (Thermo Fisher Scientific) according to the manufacturer’s recommendations using a 1:2 heavy-chain to light-chain ratio. Fab fragments were purified from cell-culture supernatant using HisTrap FF Crude columns (GE Healthcare) according to the manufacturer’s instructions. After dialysis against phosphate-buffered saline (PBS), Fab fragments were concentrated using spin filters (EMD Millipore) and analysed by SDS–PAGE, and their concentrations were determined by spectroscopy (absorbance at 280 nm).
+ Open protocol
+ Expand
6

Recombinant SOD2 Protein Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fifty milliliter SC cultures of SOD2HA C. neoformans at a starting OD600 = 0.1 were supplemented with 5 μM CuSO4 or 1 mM BCS and grown for 16 h at 30 °C, 200 rpm. Cultures were harvested and washed three times in 1X PBS +5 mM EDTA. Cell pellets were resuspended in lysis buffer (10 mM Tris [pH 7.5], 20 mM NaCl, 1 mM EDTA, 1 mM PMSF, and 1X yeast protease inhibitor) and lysed using acid-washed glass beads in a Bead Ruptor 12 (30 s on, 2 min off, ten cycles). Lysates were then pulse sonicated on ice (15 s on, 45 s off, output setting 3, four cycles) and clarified by centrifugation at 20,000g for 15 min 150 μl HA-resin (ThermoFisher Scientific) prewashed in lysis buffer was added to clarified cell extracts and incubated on rotary platform overnight at 4 °C. Resin was pelleted and washed in 3 × 500 μl PBST, followed by another 500 μl PBS. Sod2-HA was eluted using 10 × 100 μl 3 M NaSCN. Elutions were pooled and concentrated using spin filters (EMD Millipore), then buffer exchanged into 10 mM Tris (pH 8.0) using desalting columns (ThermoFisher Scientific). Concentrations were measured using the theoretical extinction coefficient of 40,910 (M−1 cm−1) at A280 nm on a Nanodrop OneC (Thermo Scientific) as well as by BCA assay (Pierce). Protein purity was assessed by SDS-PAGE analysis and Coomassie staining.
+ Open protocol
+ Expand
7

Delipidation and Proteomic Analysis of Extracellular Vesicles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolated extracellular vesicles were delipidated as described previously (10 (link)) using the protein precipitation protocol of Wessel and Flügge (50 (link)). Delipidated extracellular vesicles were resolubilized in 100 μl of 50 mM triethyl ammonium bicarbonate (TEAB) in 1:1 (vol/vol) trifluoroethanol-water. For reduction of cysteine thiols, the solution was mixed with 10 mM Tris(2-carboxyethyl) phosphine and alkylated with 12.5 mM chloroacetamide at 70°C for 30 min in the dark. Proteins were digested for 18 h at 37°C with trypsin-LysC mix (Promega) at a protein-to-protease ratio of 25:1. Tryptic peptides were first completely evaporated using a vacuum concentrator (Eppendorf) and then resolubilized in 0.05% (vol/vol) trifluoroacetic acid (TFA) in 2:98 (vol/vol) acetonitrile-water. Finally, the samples were filtered through Ultrafree-MC hydrophilic polytetrafluoroethylene (PTFE) membrane (0.2-μm pore size) spin filters (Millipore) and stored at −20°C until measurement. Each sample was measured in triplicate (three analytical replicates of three biological replicates) as follows.
+ Open protocol
+ Expand
8

Synthesis and Characterization of PEG-Peptide-DNA Nanosensors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Multivalent PEG (40 kDa, eight-arm) containing maleimide-reactive handles (JenKem Technology) was dissolved in 100 mM phosphate buffer (pH 7.0) and filtered (pore size, 0.2 μm). After filtration, the cysteine-terminated peptide–DNA conjugates were added at 2-fold molar excess to the PEG and reacted for at least 4 h at room temperature. Unconjugated molecules were separated using size-exclusion chromatography with a Superdex 200 Increase 10/300 GL column on an ÄKTA fast protein liquid chromatograph (GE Healthcare). The purified nanosensors were concentrated by spin filters (molecular weight cut-off, 10 kDa; Millipore), and quantified with a Quant-iT OliGreen ssDNA Assay Kit (Thermo Fisher Scientific). Fluorescence was read on a Tecan Infinite Pro M200 Quant-iT plate reader at λex = 485 nm, λem = 535 nm. Particles were stored at 4 °C in PBS. Dynamic light scattering (Zeta Sizer Nanoseries, Malvern Instruments) was used to characterize the hydrodynamic diameter of nanoparticles. Sequences of DNA-barcoded synthetic urine biomarkers are listed in Supplementary Table 4.
+ Open protocol
+ Expand
9

Synthesis and Characterization of HFA-modified Peptide vABNs

Check if the same lab product or an alternative is used in the 5 most similar protocols
HFA-modified peptides were synthesized by CPC Scientific (>95% purity). Briefly, the peptide substrate, Ac-CKKK(Cy5)-PEG4-Nle(OBzl)-Met(O)2-Oic-Abu-OH, was synthesized on Fmoc-Abu-CTC resin via standard Fmoc solid phase peptide synthesis. The peptide was cleaved from the resin using 30% HFIP in DCM for 30 min and subsequently coupled to the HFA reporter using DIC/HOBt coupling reagents in DCM under stirring conditions at room temperature for 2h. The finished product was deprotected in TFA for 2.5h, precipitated and washed in chilled ether 2 times, and dried under vacuum overnight. The crude peptide was then purified using RP-HPLC. For vABN synthesis, HFA-modified peptides were conjugated to 40 kDa maleimide-functionalized 8-arm PEG (Jenkem) overnight at room temperature in DI water (2:1 molar ratio of peptide to maleimide groups). Excess peptides were removed using spin filters (Millipore, 10 kDa MWCO), and completed vABNs were stored in DI water at 4°C. vABNs were visualized using TEM imaging. Samples were prepared by placing a 1 mg/mL vABN solution onto a TEM grid, wicking away the solution, and staining the sample with 2% uranyl acetate.
+ Open protocol
+ Expand
10

Structural Determination of HSA Complex

Check if the same lab product or an alternative is used in the 5 most similar protocols
HSA was purified according to a previous method (Curry et al., 1998 (link)). To prepare the HSA complex, we mixed 100 µL HSA (100 mg/mL), 380 µL 2.5 mM palmitic acid (PA), 45 µL Cu(BpT)Br (10 mM), and 45 µL of NAMI-A (10 mM) overnight. Then, the mixtures were concentrated to 100 mg/mL with a Millipore spin filter (10,000 Da cutoff). HSA complex crystals were grown using sitting drop vapor diffusion according to the following procedures (Gou et al., 2015a (link); Qi et al., 2016c (link); Gou et al., 2017 (link)). We mixed 1 µL HSA complex with an equal volume of reservoir solution containing 28–32% (w/v) polyethylene glycol 3350, 50 mM potassium phosphate (pH 7.5), 5% glycerol, and 4% DMSO. HSA complex crystals were frozen in liquid nitrogen when the crystals were picked from solution.
We used the beamline BL17U in the Shanghai Synchrotron Radiation Facility to collect X-ray diffraction data at 100 K (Wang et al., 2015 ). The HSA complex data were integrated and scaled by HKL2000 (Otwinowski & Minor, 1997 ) (Table S1). HSA complex structures were resolved by molecular replacement in CCP4i (Krojer et al., 2017 (link)), and they were refined in the PHENIX program according to the reported procedure (Adams et al., 2010 (link)) (Table S1). The HSA complex structure figures were depicted by PyMOL software (DeLano, 2004 ).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!